Iodid Bc

Potassium Iodide, the active ingredient in Iodid Bc, is an iodide presented as an oral tablet for oral use. It is employed to saturate the thyroid gland, thereby reducing uptake of radioactive iodine in individuals at risk of radiation exposure. It is especially useful for populations living near nuclear facilities or for individuals undergoing certain medical procedures involving iodine isotopes.

GNH USA supplies Iodid Bc as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to WHO GMP standards and providing the product to hospitals, pharmacies, and clinics worldwide for emergency preparedness and public health programs.

Iodid Bc (potassium iodide) acts as a thyroid blocking agent to prevent radioactive iodine uptake.

- Prophylaxis against radioactive iodine exposure: reduces thyroid absorption of radioactive iodine during nuclear incidents. - Nuclear emergency thyroid protection: provides stable iodine to saturate the gland and limit radiation dose to the thyroid. - Pre‑treatment before radioiodine therapy: decreases thyroid uptake of administered iodine‑131 to protect normal tissue.

Potassium iodide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Metallic taste: transient metallic or salty taste in the mouth. - Nausea or vomiting: mild gastrointestinal upset after ingestion. - Stomach discomfort: abdominal pain or cramping. - Mild rash or itching: skin irritation at the site of contact.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis requiring immediate medical attention. - Iodide‑induced hyperthyroidism: excessive thyroid hormone production, especially in individuals with underlying thyroid disease. - Iodide‑induced hypothyroidism: reduced thyroid hormone synthesis leading to fatigue, weight gain, and cold intolerance.

When using potassium iodide, several precautions should be observed to ensure safety and effectiveness. - Assess iodine status: evaluate baseline iodine intake before administration. - Avoid in known iodine allergy: contraindicated for patients with hypersensitivity to iodide. - Monitor thyroid function: check thyroid hormone levels in patients with pre‑existing thyroid disorders. - Use with caution in pregnancy: potential effects on fetal thyroid require risk‑benefit assessment. - Use with caution in breastfeeding: consider infant exposure through breast milk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium iodide can interact with several medicines, altering its efficacy or increasing risk of adverse effects.

Major Interactions (Avoid): - Lithium: concurrent use may exacerbate lithium toxicity and affect thyroid function. - Amiodarone: high iodine content can compound thyroid effects, increasing risk of dysfunction. - Antithyroid drugs (e.g., methimazole, propylthiouracil): may reduce the blocking effect of potassium iodide.

Moderate Interactions (Monitor Closely): - Radioactive iodine therapy: potassium iodide can negate therapeutic uptake, requiring timing adjustments. - Thyroid hormone replacement (levothyroxine): dosage may need modification due to altered iodine balance. - Diuretics (especially thiazides): can affect potassium levels, necessitating electrolyte monitoring.